CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigator Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0679

Supertest 450

Filed under Injectable Oils. The bureau holds 125 laboratory returns for this compound from 44 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

44 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
Tianjin Finder Chemical TFCCASE #VI-2026-0693 A 6 10.0 9.9 10.0 14 Nov 2025 16 Apr 2026
WuXi TIDESCASE #VI-2026-0335 A 4 10.0 10.0 10.0 27 Jan 2026 19 Jun 2026
Sigma-AldrichCASE #VI-2026-0829 A 4 10.0 9.9 10.0 13 Feb 2026 12 Aug 2026
AsymchemCASE #VI-2026-0091 A 4 10.0 9.9 10.0 15 May 2026 19 Aug 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936 A 3 10.0 10.0 10.0 1 Mar 2026 19 May 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379 A 3 10.0 10.0 10.0 21 Mar 2026 13 Jun 2026
GenScript PeptidesCASE #VI-2026-0860 A 3 10.0 9.9 10.0 12 May 2026 5 Aug 2026
Thermo Fisher ScientificCASE #VI-2026-0142 A 3 10.0 9.9 10.0 24 Apr 2026 16 Aug 2026
SinoPepCASE #VI-2026-0387 A 3 10.0 9.9 10.0 8 Mar 2026 7 Jun 2026
Sangon BioCASE #VI-2026-0671 A 2 10.0 10.0 10.0 4 May 2026 21 May 2026
Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558 X 1 10.0 10.0 10.0 28 Mar 2025 28 Mar 2025
Planet PeptideCASE #VI-2026-0092 X 1 10.0 10.0 10.0 2 Apr 2025 2 Apr 2025
HomopeptideCASE #VI-2026-0760 A 4 9.9 9.9 10.0 24 May 2026 24 May 2026
JEEP PeptidesCASE #VI-2026-0457 A 4 9.9 9.9 10.0 11 Feb 2026 4 Jul 2026
PolyPeptide GroupCASE #VI-2026-0143 A 4 9.9 9.9 10.0 27 Feb 2026 27 Jun 2026
AmbioPharmCASE #VI-2026-0177 A 4 9.9 9.9 10.0 3 Jun 2026 14 Jul 2026
QYAOBIOCASE #VI-2026-0861 A 3 9.9 9.9 9.9 15 Nov 2025 21 May 2026
BachemCASE #VI-2026-0314 A 3 9.9 9.9 10.0 9 Apr 2026 9 Jul 2026
Kerui PeptidesCASE #VI-2026-0626 A 3 9.9 9.9 10.0 3 May 2026 5 Jul 2026
Flourishglobal PeptideCASE #VI-2026-0630 A 3 9.9 9.9 9.9 24 Jun 2026 11 Jul 2026
Hubei JianxiangCASE #VI-2026-0048 A 2 9.9 9.9 9.9 8 Feb 2026 21 Feb 2026
Mokemei BiotechnologyCASE #VI-2026-0540 A 2 9.9 9.9 10.0 12 Dec 2025 15 May 2026
Chinese Peptide CompanyCASE #VI-2026-0184 A 2 9.9 9.9 10.0 6 Jan 2026 26 Mar 2026
Shanghai Sigma AudleyCASE #VI-2026-0505 A 2 9.9 9.9 10.0 2 Apr 2026 1 Jun 2026
Hybio PharmaceuticalCASE #VI-2026-0065 A 2 9.9 9.9 10.0 26 Dec 2025 17 Jun 2026
Peptide SciencesCASE #VI-2026-0867 X 1 9.8 9.8 9.8 6 May 2025 6 May 2025
Bulk Peptide WholesaleCASE #VI-2026-0319 X 1 9.3 9.3 9.3 2 Apr 2025 2 Apr 2025
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 A 7 8.9 6.2 9.9 24 May 2026 24 May 2026
Evolve BioPepCASE #VI-2026-0755 X 1 8.5 8.5 8.5 9 Jun 2025 9 Jun 2025
Henan Sahe PeptideCASE #VI-2026-0894 X 1 8.4 8.4 8.4 7 May 2025 7 May 2025
Shanghai Sigma Audley SSACASE #VI-2026-0486 A 6 8.2 7.0 8.9 24 May 2026 24 May 2026
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 A 4 8.2 6.8 9.0 24 May 2026 24 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704 A 8 8.1 7.4 8.6 24 May 2026 24 May 2026
Huayi BiotechnologyCASE #VI-2026-0243 X 1 8.1 8.1 8.1 8 Jul 2025 8 Jul 2025
Qingdao Sigma Chemical QSCCASE #VI-2026-0538 A 2 8.0 7.1 8.8 25 May 2026 25 May 2026
TCICASE #VI-2026-0650 X 1 7.8 7.8 7.8 6 May 2025 6 May 2025
Polaris PeptidesCASE #VI-2026-0839 X 6 7.5 4.9 9.7 14 Jan 2025 17 May 2026
Peptide HavenCASE #VI-2026-0898 X 1 7.5 7.5 7.5 16 Mar 2025 16 Mar 2025
Xian Yihang TechnologyCASE #VI-2026-0656 X 3 7.0 6.2 7.6 28 Mar 2025 20 May 2026
Bio PepzCASE #VI-2026-0436 X 1 6.7 6.7 6.7 6 May 2025 6 May 2025
Platinum CryoCASE #VI-2026-0406 X 1 5.8 5.8 5.8 6 May 2025 6 May 2025
TydesCASE #VI-2026-0493 X 3 4.5 2.8 5.9 8 Jul 2025 21 May 2026
PurePEPSCASE #VI-2026-0552 X 1 2.5 2.5 2.5 3 Jul 2025 3 Jul 2025
LOOKBiotechCASE #VI-2026-0807 X 1 0.0 0.0 0.0 25 Apr 2025 25 Apr 2025

Open any subject to view the batch-level evidence for Supertest 450 alone.